Home/Filings/4/0001437749-19-013384
4//SEC Filing

Horvath Susan 4

Accession 0001437749-19-013384

CIK 0001029125other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 4:54 PM ET

Size

6.5 KB

Accession

0001437749-19-013384

Insider Transaction Report

Form 4
Period: 2019-06-30
Horvath Susan
V.P. of Finance & CFO
Transactions
  • Conversion

    Convertible Promissory Note

    2019-06-3023,6250 total
    Exercise: $3.50From: 2018-12-31Exp: 2019-06-30Common Stock (7,084 underlying)
  • Conversion

    Common Stock

    2019-06-30+7,0847,084 total
Footnotes (1)
  • [F1]All amounts due under the note automatically converted into shares of common stock of the Issuer based on conversion price of $3.50 per shares upon maturity.

Issuer

Sun BioPharma, Inc.

CIK 0001029125

Entity typeother

Related Parties

1
  • filerCIK 0001322846

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:54 PM ET
Size
6.5 KB